Navigation Links
Intarcia Therapeutics Appoints Gino Santini To Its Board Of Directors
Date:7/26/2013

nded periods of time.

Data from Intarcia's ITCA 650 Phase 2 program have demonstrated significant and sustained reductions in HbA1c and body weight over 48 weeks of treatment with a marked reduction in the GI adverse events typically associated with the self-injection products in this class. ITCA 650 is an investigational new therapy and is not currently approved by any regulatory authority. Exenatide, the active agent in ITCA 650, is a glucagon-like peptide-1 (GLP-1) receptor agonist currently marketed globally as twice-daily and once-weekly self-injection therapies for type 2 diabetes. Upon approval, ITCA 650 would represent the first injection-free GLP-1 therapy that can deliver a full year of treatment from a single minipump placement. Intarcia's robust intellectual property portfolio protects ITCA 650 through 2031.

About Intarcia Therapeutics, Inc.
Intarcia Therapeutics, Inc. is a biopharmaceutical company developing therapies to enhance treatment outcomes by optimizing and improving the efficacy, continuous administration and tolerability of drug therapies. In addition, delivering medicines just once or twice yearly virtually ensures patient adherence and compliance, which is very poor in most chronic diseases. Intarcia's drug development expertise and competitive edge are demonstrated by its abilities to stabilize proteins and peptides at above-body temperature and to deliver them in a constant and consistent manner via Intarcia's proprietary technology platform. Intarcia is pursuing a Phase 3-stage development program for type 2 diabetes and has additional programs ongoing for weight regulation to control obesity. For more information on the Company, please visit www.intarcia.com.

Intarcia and its logo are registered trademarks of Intarcia Therapeutics, Inc.


'/>"/>
SOURCE Intarcia Therapeutics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Intarcia Appoints Owen Hughes Chief Business Officer and Head of Corporate Development
2. Intarcia Enrolls First Patients in "FREEDOM" Global Phase 3 Program for ITCA 650 in Type 2 Diabetes
3. Intarcia Supports American Diabetes Association Call For Independent Review Of Incretin-Based Therapies
4. Cell Therapeutics, Inc. (CTI) to Report First Quarter Financial Results on April 20
5. Faruqi & Faruqi, LLP Encourages Investors Who Suffered Substantial Losses Investing in Chelsea Therapeutics International, Ltd. to Contact the Firm
6. Argos Therapeutics Secures $25 million Series D Financing to Commence Phase 3 ADAPT Study in Patients with Metastatic Renal Cell Carcinoma (mRCC) in Mid-2012
7. Novelos Therapeutics Announces Successful Completion of First Cohort In Lung Cancer Trial With I-124-CLR1404 (LIGHT) Cancer-Targeted PET Imaging Agent at UW Carbone Cancer Center
8. Zacks Industry Outlook Highlights: Eli Lilly, Forest Labs, ViroPharma, Novartis and United Therapeutics
9. Oxford BioTherapeutics Appoints Senior Industry Leader to Head its New Clinical Development Operations in Basel, Switzerland
10. Nektar Therapeutics Reports Financial Results for the First Quarter of 2012
11. Cara Therapeutics Licenses Novel Kappa Opioid Agonist, CR845, to Chong Kun Dang Pharmaceutical Corporation For South Korean Market
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... Research and Markets ... the "Craniomaxillofacial Implants Market - Global Industry ... - 2022" report to their offering. ... studies the current and future prospects of the ... in the global market due to increasing facial ...
(Date:7/28/2015)... , July 28, 2015  PD-Rx Pharmaceuticals, ... announced that it has partnered with Dobson Technologies, ... as a Service (IaaS) product. PD-Rx ... practices across the United States.  Using Dobson Technologies, ... recovery and business continuity, ensure regulatory compliance, and ...
(Date:7/28/2015)... WORTH, Texas , July 28, 2015 ... "Global Dermatology Devices Market by Type (Dermatology Treatment Devices, ... CT), Dermatoscopes, Microscopes]), by Application, by Geography - Analysis ... is expected to reach $11.88 billion by 2019, at ... Browse through the TOC of Global Dermatology Devices ...
Breaking Medicine Technology:Global Craniomaxillofacial Implants (Plate and Screw Fixator Systems, Bone Graft Substitutes, Distraction Systems, and TMJ Replacement Devices) Market Analysis 2014-2022 2PD-Rx Partners With Dobson Technologies 2Global Dermatology Devices Market to be Worth $11.88 Billion by 2019 2Global Dermatology Devices Market to be Worth $11.88 Billion by 2019 3
(Date:7/28/2015)... (PRWEB) , ... July 28, 2015 , ... ... new Total Heart Center at Memorial Regional Hospital, providing expert, streamlined total advanced ... will be suited to provide extensive heart services under one roof, including the ...
(Date:7/28/2015)... ... 2015 , ... Santa Rosa’s The Press Democrat announced its annual report of the very best ... Dr. Heather Furnas took the top spot as the Best Cosmetic Surgeons in Sonoma ... proud to be bestowed such a prestigious title. , The Press Democrat was ...
(Date:7/28/2015)... ... July 28, 2015 , ... The Triumph Modular, Redefining Modular™ ... education, resource library, floor plans, educational blog and wide use of imagery. The ... posts with valuable links to useful reports by industry experts. Comments are welcomed ...
(Date:7/28/2015)... Miami, Florida (PRWEB) , ... July 28, 2015 ... ... engineer of patented products, announces Shelled Out, a new household invention that makes ... to earn $253.4 billion by 2020,” says Scott Cooper, CEO and Creative Director ...
(Date:7/28/2015)... ... July 28, 2015 , ... World ... Lost and Found, a breakthrough technological invention. It is a wearable personal ... consumer electronic industry reached a record high of $211.3 billion in 2014," says ...
Breaking Medicine News(10 mins):Health News:Memorial Cardiac And Vascular Institute Centralizes Cardiac Care Through It's New "Total Heart Center" At Memorial Regional Hospital 2Health News:Dr. Canales and Dr. Furnas Honored as Sonoma County’s Best Cosmetic Surgeons 2Health News:Triumph Modular Launches Refreshed Modular Building Industry Website 2Health News:Essential Bang For Your Buck Kitchen Items Presented By World Patent Marketing 2Health News:Essential Bang For Your Buck Kitchen Items Presented By World Patent Marketing 3Health News:Essential Bang For Your Buck Kitchen Items Presented By World Patent Marketing 4Health News:Essential Bang For Your Buck Kitchen Items Presented By World Patent Marketing 5Health News:Getting Back to Basic with Bluetooth Is What the World Patent Marketing Review Team and Lost and Found Are All About 2Health News:Getting Back to Basic with Bluetooth Is What the World Patent Marketing Review Team and Lost and Found Are All About 3Health News:Getting Back to Basic with Bluetooth Is What the World Patent Marketing Review Team and Lost and Found Are All About 4Health News:Getting Back to Basic with Bluetooth Is What the World Patent Marketing Review Team and Lost and Found Are All About 5
... By Dennis Thompson HealthDay Reporter , FRIDAY, ... that girls and young women be vaccinated against human papillomavirus, ... cervical cancer, but that recommendation does not extend to boys ... debate that,s been simmering over whether males also should be ...
... 23 (HealthDay News) -- Researchers have identified five new genes ... and coronary artery disease -- the most common cause of ... new study. The international consortium said their discovery ... new treatments for the condition. In conducting the study, ...
... the worst kala azar outbreak in a decade. Collaboration ... (LEAP) has resulted in the development of a new ... the length of treatment from a 30 day course ... are taking the necessary regulatory measures to use it ...
... A little motivation for parents could go a long ... their own care, a Wayne State University researcher believes. ... in WSU,s School of Medicine, has received a two-year, ... Digestive and Kidney Diseases of the National Institutes of ...
... , FRIDAY, Sept. 23 (HealthDay News) -- New research ... women who have survived breast cancer from getting ... ovarian cancer. "Depression can make people more ... likely to ignore recommendations to reduce their risk," said ...
... (HealthDay News) -- A cardiac rehabilitation program appeared to ... stroke among patients who have suffered mild strokes or ... have found. "Overall, following the cardiac rehab intervention, ... their risk profile," study senior investigator Neville Suskin, medical ...
Cached Medicine News:Health News:CDC Considers Vaccinating Boys, Not Just Girls, for HPV 2Health News:CDC Considers Vaccinating Boys, Not Just Girls, for HPV 3Health News:Scientists ID More Genes Linked to Heart Disease 2Health News:New treatment for kala azar, the most deadly parasitic disease after malaria 2Health News:New treatment for kala azar, the most deadly parasitic disease after malaria 3Health News:Wayne State University study aims to improve diabetes management in high-risk youth 2Health News:Wayne State University study aims to improve diabetes management in high-risk youth 3Health News:Depression After Cancer Keeps Some From Follow-Up Care 2Health News:Cardiac Rehab May Cut Risk Factors After Mini-Stroke 2
... factor I (IGF-I or somatomedin C) is a ... It acts as a potent mitogen of cellular ... cell-surface receptors. In the circulation, IGF-I is bound ... the actions of IGF-I by modulating the interaction ...
Urovac bladder evacuator with adaptor...
The Urology C-Arm Table features motorized actuation of height, X-Y, lateral roll and Trendelenburg motions of the tabletop, and is fully accessorized for urologic procedures....
... The UroVantage from HealthTronics ... the most versatile urology ... technological leap forward in ... for urologists by urologists, ...
Medicine Products: